![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current 0ACX market cap is 0. The company's latest EPS is USD and P/E is N/A.
Year End December 30 2022 | 2021 | 2022 |
---|---|---|
USD ($) | USD ($) | |
Total Revenue | 0 | 0 |
Operating Income | -374.08M | -212.26M |
Net Income | -381.07M | -216.21M |
Year End December 30 2022 | 2021 | 2022 |
---|---|---|
USD ($) | USD ($) | |
Total Assets | 629.64M | 444.31M |
Total Liabilities | 138.08M | 108.14M |
Total Equity | 491.55M | 336.17M |
Year End December 30 2022 | 2021 | 2022 |
---|---|---|
USD ($) | USD ($) | |
Operating | -135.11M | -200.55M |
Investing | 63.26M | -931k |
Financing | 660.15M | 457k |
Market Cap | 0 |
Price to Earnings Ratio | N/A |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0 |
Price to Book Ratio | 0 |
Dividend Yield | - |
Shares Outstanding | 0 |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0 (0%) |
Company Name | Centessa Pharmaceuticals Plc |
Address |
3rd floor cheshire WA14 2DT |
Website | https://www.centessa.com |
Industry | coml physical, biologcl resh (8731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions